GlaxoSmithKline Consumer launches liquid and tablet versions of ‘Eno’ brand

04 Jul 2013 Evaluate

In a bid to strengthen its leadership position in the digestive antacid market in India, GlaxoSmithKline Consumer Healthcare has launched liquid and tablet versions of its Eno brand. So far, Eno has been available only in powder form. Eno's six-tablet pack will be available at Rs 8, while its 170-ml liquid bottle is priced at Rs 68.

‘Eno’ is company’s third-largest brand, after Horlicks and Boost, which together accounted for 80% of the company's turnover of Rs 940 crore in 2012-13. The digestive antacid market in India is estimated at Rs 800 crore, of which powders constitute about 45%.

GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 2506.20
Britannia Inds 4790.85
Varun Beverages 1485.75
Marico 513.80
Hatsun Agro Product 1094.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.